Prenatal drug exposure as a risk factor for cerebral palsy and other developmental deficits
- PMID: 34553769
- DOI: 10.1111/dmcn.15065
Prenatal drug exposure as a risk factor for cerebral palsy and other developmental deficits
Comment on
-
Intrauterine drug exposure as a risk factor for cerebral palsy.Dev Med Child Neurol. 2022 Apr;64(4):453-461. doi: 10.1111/dmcn.15050. Epub 2021 Sep 16. Dev Med Child Neurol. 2022. PMID: 34528707 Free PMC article.
References
-
- Behnk M, Smith VC, Committeeon Substance Abuse; Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics 2013; 131: e1009-24.
-
- Benninger KL, Purnell J, Conroy S, Jackson K, Batterson N, Neel ML, et al. Intrauterine drug exposure as a risk factor for cerebral palsy. Dev Med Child Neurol 2022; 64: 453-61.
-
- Salzwedel A, Chen G, Chen Y, Grewen K, Gao W. Functional dissection of prenatal drug effects on baby brain and behavioral development. Hum Brain Mapp 2020; 41: 4789-803.
-
- Salzwedel AP, Grewen KM, Vachet C, Gerig G, Lin W, Gao W. Prenatal drug exposure affects neonatal brain functional connectivity. J Neurosci 2015; 35: 5860-9.
-
- Volkow ND, Gordon JA, Freund MP. The healthy brain and child development study-shedding light on opioid exposure, COVID-19, and health disparities. JAMA Psychiatry 2021; 78: 471-2.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical